These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 28031933)

  • 1. Opportunities in low-level radiocarbon microtracing: applications and new technology.
    Vuong LT; Song Q; Lee HJ; Roffel AF; Shin SH; Shin YG; Dueker SR
    Future Sci OA; 2016 Mar; 2(1):FSO74. PubMed ID: 28031933
    [No Abstract]   [Full Text] [Related]  

  • 2. Radiocarbon Tracers in Toxicology and Medicine: Recent Advances in Technology and Science.
    Malfatti MA; Buchholz BA; Enright HA; Stewart BJ; Ognibene TJ; McCartt AD; Loots GG; Zimmermann M; Scharadin TM; Cimino GD; Jonas BA; Pan CX; Bench G; Henderson PT; Turteltaub KW
    Toxics; 2019 May; 7(2):. PubMed ID: 31075884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accelerator mass spectrometry-enabled studies: current status and future prospects.
    Arjomand A
    Bioanalysis; 2010 Mar; 2(3):519-41. PubMed ID: 20440378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laser-based radiocarbon detection in the laboratory: How soon?
    Murnick DE
    J Labelled Comp Radiopharm; 2019 Sep; 62(11):768-775. PubMed ID: 31369168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current perspectives of 14C-isotope measurement in biomedical accelerator mass spectrometry.
    Lappin G; Garner RC
    Anal Bioanal Chem; 2004 Jan; 378(2):356-64. PubMed ID: 14624324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accelerator mass spectrometry offers new opportunities for microdosing of peptide and protein pharmaceuticals.
    Salehpour M; Ekblom J; Sabetsky V; Håkansson K; Possnert G
    Rapid Commun Mass Spectrom; 2010 May; 24(10):1481-9. PubMed ID: 20411588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Issues and opportunities in accelerator mass spectrometry for stable isotopes.
    Matteson S
    Mass Spectrom Rev; 2008; 27(5):470-84. PubMed ID: 18553556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in biomedical applications of accelerator mass spectrometry.
    Hah SS; Henderson PT; Turteltaub KW
    J Biomed Sci; 2009 Jun; 16(1):54. PubMed ID: 19534792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomedical applications of accelerator mass spectrometry-isotope measurements at the level of the atom.
    Barker J; Garner RC
    Rapid Commun Mass Spectrom; 1999; 13(4):285-93. PubMed ID: 10097404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human ADME for YH12852 using wavelength scanning cavity ring-down spectroscopy (WS-CRDS) after a low radioactivity dose.
    Kim A; Dueker SR; Dong F; Roffel AF; Lee SW; Lee H
    Bioanalysis; 2020 Jan; 12(2):87-98. PubMed ID: 31928227
    [No Abstract]   [Full Text] [Related]  

  • 11.
    Szidat S
    Chimia (Aarau); 2020 Dec; 74(12):1010-1014. PubMed ID: 33357296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Automated combustion accelerator mass spectrometry for the analysis of biomedical samples in the low attomole range.
    van Duijn E; Sandman H; Grossouw D; Mocking JA; Coulier L; Vaes WH
    Anal Chem; 2014 Aug; 86(15):7635-41. PubMed ID: 25033319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accelerator mass spectrometry in biomedical dosimetry: relationship between low-level exposure and covalent binding of heterocyclic amine carcinogens to DNA.
    Turteltaub KW; Felton JS; Gledhill BL; Vogel JS; Southon JR; Caffee MW; Finkel RC; Nelson DE; Proctor ID; Davis JC
    Proc Natl Acad Sci U S A; 1990 Jul; 87(14):5288-92. PubMed ID: 2371271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C Analysis via Intracavity Optogalvanic Spectroscopy.
    Murnick D; Dogru O; Ilkmen E
    Nucl Instrum Methods Phys Res B; 2010 Apr; 268(7-8):708-711. PubMed ID: 20448803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accelerator mass spectrometry of small biological samples.
    Salehpour M; Forsgard N; Possnert G
    Rapid Commun Mass Spectrom; 2008 Dec; 22(23):3928-34. PubMed ID: 18980253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microdosing: a valuable tool for accelerating drug development and the role of bioanalytical methods in meeting the challenge.
    Ings RM
    Bioanalysis; 2009 Oct; 1(7):1293-305. PubMed ID: 21083052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenging developments in three decades of accelerator mass spectrometry at ETH: from large particle accelerators to table size instruments.
    Suter M
    Eur J Mass Spectrom (Chichester); 2010; 16(3):471-8. PubMed ID: 20530832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracavity optogalvanic spectroscopy. An analytical technique for 14C analysis with subattomole sensitivity.
    Murnick DE; Dogru O; Ilkmen E
    Anal Chem; 2008 Jul; 80(13):4820-4. PubMed ID: 18533685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accelerator mass spectrometry analysis of background (14)C-concentrations in human blood: aiming at reference data for further microdosing studies.
    Minamimoto R; Hamabe Y; Miyaoka T; Hara T; Yoshida K; Oka T; Inoue T
    Ann Nucl Med; 2008 Dec; 22(10):883-9. PubMed ID: 19142707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New protocol for compound-specific radiocarbon analysis of archaeological bones.
    Deviese T; Comeskey D; McCullagh J; Bronk Ramsey C; Higham T
    Rapid Commun Mass Spectrom; 2018 Mar; 32(5):373-379. PubMed ID: 29247560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.